TSPAN33 抗体 (AA 107-156)
Our Local Distributor
北京 101111
Quick Overview for TSPAN33 抗体 (AA 107-156) (ABIN6741379)
抗原
See all TSPAN33 抗体适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 107-156
-
特异性
- Human TSPAN33
-
预测反应
- Percent identity by BLAST analysis: Rat, Dog, Horse, Guinea pig (100%) Zebrafish (85%).
-
纯化方法
- Immunoaffinity purified
-
免疫原
-
Synthetic peptide located between aa107-156 of human TSPAN33 (Q86UF1, NP_848657). Percent identity by BLAST analysis: Human, Chimpanzee, Gorilla, Gibbon, Galago, Marmoset, Mouse, Rat, Elephant, Dog, Bovine, Bat, Rabbit, Horse, Pig, Opossum, Guinea pig, Zebrafish (100%), Platypus, Xenopus (92%), Stickleback (85%).
Type of Immunogen: Synthetic peptide -
亚型
- IgG
-
-
anti-Tetraspanin 33 (TSPAN33) (AA 118-235) antibody
TSPAN33 适用: 人 ELISA, IHC, IF 宿主: 兔 Polyclonal unconjugated
anti-Tetraspanin 33 (TSPAN33) (AA 254-283), (C-Term) antibodyTSPAN33 适用: 人 WB, FACS, IHC (p) 宿主: 兔 Polyclonal RB23231 unconjugated
anti-Tetraspanin 33 (TSPAN33) (AA 254-283), (C-Term) antibodyTSPAN33 适用: 人 WB, FACS, IHC (p), EIA 宿主: 兔 Polyclonal unconjugated
anti-Tetraspanin 33 (TSPAN33) (C-Term) antibodyTSPAN33 适用: 人 WB, IHC 宿主: 兔 Polyclonal unconjugated
anti-Tetraspanin 33 (TSPAN33) antibodyTSPAN33 适用: 人, 小鼠, 大鼠 WB 宿主: 兔 Polyclonal unconjugated
anti-Tetraspanin 33 (TSPAN33) (AA 200-249) antibodyTSPAN33 适用: 人, 小鼠, 大鼠, 马 WB 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as second antibody. ELISA titer in peptide based assay: 1:312500. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Distilled water
-
浓度
- Lot specific
-
缓冲液
- Lyophilized from PBS with 2 % sucrose
-
注意事项
- Avoid repeat freeze-thaw cycles.
-
储存条件
- 4 °C,-20 °C
-
储存方法
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
-
